Macrophage L-type Ca2+ channel antagonists alter Chlamydia pneumoniae MOMP and HSP-60 mRNA gene expression, and improve antibiotic susceptibility

Immunobiology

Volumn 207, Issue 4, 2003, Pages 237-245

  Azenabor, Anthony A ^a   Chaudhry, Aziz U ^a   Yang, Shoua ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHELATING AGENT; CALCIUM ION; DOXYCYCLINE; ERYTHROMYCIN; HEAT SHOCK PROTEIN 60; MESSENGER RNA; NIFEDIPINE; NIMODIPINE; OUTER MEMBRANE PROTEIN; RIFAMPICIN;

ANIMAL CELL; ANTIBIOTIC SENSITIVITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CHLAMYDOPHILA PNEUMONIAE; CHRONICITY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MACROPHAGE; MACROPHAGE MIGRATION INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0042978739     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00238     Document Type: Article

References (23)

1. Airenne S, Surcel HM, Alakarppa H, Laitinen K, Paavonen J, Saikku P and Laurila A. 1999. Chlamydia pneumoniae infection in human monocytes. Infect. Immun. 67: 1445-1449.
2. 2+ channel activation. Med. Microbiol. Immunol. In press.
3. 2+ dependent reactive nitrogen and oxygen species. J. Infect. 46: 120-128.
4. Berridge MJ, Bootmen MD and Lipp P. 1998. Calcium - a life and death signal. Nature 395: 645-648.
5. Bustin SA. 2000. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25: 169-193.
6. Bustin SA. 2002. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J. Mol. Endocrinol. 29: 23-39.
7. Chomczynski P and Sacchi N. 1987. Single - step method of RNA isolation by acid guanidinium thiocynate - phenol - chloroform extraction. Anal. Biochem. 162: 156-159.
8. de la Pompa JL, Timmerman LA, Takimoto H, Yoshida H, Elia AJ, Samper E, Potter J, Wakeham A, Marengere L, Langille BL, Crabtree GR and Mak TW. 1998. Role of the NF - ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392: 182-186.
9. Gaydos CA, Quinn CT, Bobo LD and Eiden JJ. 1992. Similarity of Chlamydia pneumoniae strains in variable domain IV region of the major outer membrane protein gene. Infect. Immun. 60: 5319-5323.
10. Gaydos CA, Summersgill JT, Sahrey NN, Ramirez JA and Quinn T. 1996. Replication of Chlamydia pneumoniae in vitro in human monocytes, endothelial cells and aortic smooth muscle cells. Infect. Immun. 64: 1614-1620.
11. Gieffers J, Solbach W and Maass M. 1999. Activity of antibiotic in eliminating Chlamydia pneumoniae cardiovascular strains from cell types involved in the pathogenesis of atherosclerosis. Clin. Microbiol. Infect. 5(Suppl 3): 381.
12. Gieffers J, Fullgraf H, Jahn J, Klinger M, Dalhoff K, Katus H, Solbach W and Maass M. 2002. Chlamydia pneumoniae infection in circulating human monocyte is refractory to antibiotic treatment. Circulation 103: 351-356.
13. Hahn DK, Azenabor AA, Beatty W and Byrne GI. 2002. Chlamydia pneumoniae as respiratory pathogen. Front Biosci. 7: e66-e76.
14. Kaukoranta-Toluarea SS, Laitinen K, Saikku P and Leinonen M. 1994. Chlamydia pneumoniae multiplies in human endothelial cells in vitro. Microb. Pathog. 16: 313-319.
15. Khan MA, Potter CW and Sharrad RM. 1996. A reverse transcriptase-PCR based assay for in vitro antibiotic susceptibility testing of Chlamydia pneumoniae. J. Antimicrob. Chemother. 37: 677-685.
16. Kleindienst R, Xu Q, Willeit J, Waldenberger FR, Weimann S and Wick G. 1993. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/ beta or gamma/delta receptor in human atherosclerotic lesions. Am. J. Pathol. 142: 1927-1937.
17. Kol A, Bourcier T, Lichtmon AH and Libby P. 1999. Chlamydial and human heat shock protein 60s activates human vascular endothelium, smooth muscle cells, and macrophages. J. Clin. Invest. 103: 571-577.
18. McMillan GC. 1995. Historical review of research in atherosclerosis. Adv. Exp. Med. Biol. 369: 1-6.
19. Meijer A, Roholl PJM, Gielis-Proper SK and Ossewaarde JM. 2000. Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions. J. Clin. Pathol. 53: 911-916.
20. Morre SA, Sillekens PTG, Jacobs MV, deBlok S, Ossewaarde JM, Van Aarle P, Van Gemen B, Walboomers JM, Meijer CJ and Van Den Brule AJ. 1998. Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA detection by nucleic acid sequence based amplification. Mol. Pathol. 51: 149-154.
21. Sheridan GEC, Masters CI, Shallcross JA and Mackey BM. 1998. Detection of mRNA by reverse transcription-PCR as an indicator of viability in Escherichia coli cells. Appl. Environ. Microbiol. 64: 1313-1318.
22. Shor A., Phillips JI, Ong G, Thomas BJ and Taylor-Robinson D. 1998. Chlamydia pneumoniae in atherome: consideration of criteria for causality. J. Clin. Pathol. 51: 812-817.
23. Valassina M, Migliorini L, Sanson A, Sani G, Corsaro D, Cusi MG, Valensin PE and Cellesi C. 2001. Search for Chlamydia pneumoniae genes and their expression in atherosclerotic plaques of carotid arteries. J. Med. Microbiol. 50: 228-232.